Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Suzhou Ribo Life Science patents FXI-targeting siRNA

Dec. 14, 2020

Week 48 data reported from phase III PEGASUS trial of pegcetacoplan in PNH

Dec. 10, 2020

Editas submits IND for EDIT-301 for sickle cell disease

Dec. 10, 2020

FDA approves oral once-daily Orladeyo to prevent HAE attacks

Dec. 4, 2020

Biotest presents compositions comprising recombinant factor VIII protein

Dec. 3, 2020

Enrollment ongoing in phase III study of marzeptacog alfa

Dec. 3, 2020

University of Bern, Silence Therapeutics describe nucleic acids inhibiting PROS1

Nov. 30, 2020

Evrenzo approved in Japan for CKD anemia in adults not on dialysis

Nov. 27, 2020

Late events dog gene therapy

Nov. 24, 2020

Functional analysis complements sequencing

Nov. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...